These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12068274)

  • 1. [Current debates on rectal cancer].
    Lasser P
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B78-85. PubMed ID: 12068274
    [No Abstract]   [Full Text] [Related]  

  • 2. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?
    Watanabe T; Matsuda K; Nozawa K; Kobunai T
    Ann Surg; 2008 Aug; 248(2):342-3; author reply 343. PubMed ID: 18650647
    [No Abstract]   [Full Text] [Related]  

  • 3. The current management of rectal cancer.
    Ross HM; Mahmoud N; Fry RD
    Curr Probl Surg; 2005 Feb; 42(2):72-131. PubMed ID: 15735619
    [No Abstract]   [Full Text] [Related]  

  • 4. Rectal cancer.
    Zampino MG; Labianca R; Beretta GD; Magni E; Gatta G; Leonardi MC; Chiappa A; Biffi R; de Braud F; Wils J
    Crit Rev Oncol Hematol; 2009 May; 70(2):160-82. PubMed ID: 19059790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphincter preservation therapy for rectal cancer.
    Aitken C; Breen E; Mamon HJ
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 9. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence after total mesorectal excision.
    Bokey EL; Chapuis PH; Dent OF
    Dis Colon Rectum; 2005 Jun; 48(6):1323; author reply 1323. PubMed ID: 15906122
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.
    Gavioli M; Luppi G; Losi L; Bertolini F; Santantonio M; Falchi AM; D'Amico R; Conte PF; Natalini G
    Dis Colon Rectum; 2005 Oct; 48(10):1851-7. PubMed ID: 16132481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers of local relapse in rectal cancer: are we any further forward?
    Johnston PG
    J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
    [No Abstract]   [Full Text] [Related]  

  • 13. Multidisciplinary treatment of resectable rectal cancer.
    Ayala DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of rectal cancer local recurrence: population-based survey and validation of the Swedish rectal cancer registry.
    Jörgren F; Johansson R; Damber L; Lindmark G
    Colorectal Dis; 2010 Oct; 12(10):977-86. PubMed ID: 19438885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
    Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS
    J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the treatment of rectal cancer: a population based study.
    Martling A; Granath F; Cedermark B; Johansson R; Holm T
    Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer.
    Hasdemir O; Cöl C; Yalçin E; Tunç G; Bilgen K; Kuçukpinar T
    Hepatogastroenterology; 2005; 52(62):455-9. PubMed ID: 15816456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
    McGartland LP; Mulcahy MF; Benson AB
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):806-14. PubMed ID: 16166957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.